Cirrhotic NASH patients exhibited significant differences, showing lower LDL-apoB production rates and reduced HDL-bound protein levels compared to those in their non-cirrhotic counterparts. The gene discussed is APOB; the disease is metabolic dysfunction-associated steatohepatitis.